Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (191-200 of 245) with videos related to

Pageof 25
Sort By:
European Heart Journal|July 31, 2008
Discontinuation of statin therapy following an acute myocardial infarction: a population-based studyStella S Daskalopoulou, Joseph A C Delaney, Kristian B Filion, et al.
BMJ (Clinical Research Ed.)|November 7, 2013
Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodologySteven T Bird, Joseph A C Delaney, James M Brophy, et al.
Heart (British Cardiac Society)|May 21, 2014
Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndromeChristopher Labos, Rui Hao Leo Wang, Louise Pilote, et al.
Current Problems in Diagnostic Radiology|May 26, 2023
Imaging Utilization Patterns in the Follow-Up of Extremity Soft Tissue Sarcomas in the United StatesNatalia Gorelik, Elizabeth Y Rula, Casey E Pelzl, et al.
The American Journal of Cardiology|January 25, 2011
Analysis of willingness to pay for implantable cardioverter-defibrillator therapyDominika Nowakowska, Jason R Guertin, Aihua Liu, et al.
International Journal of Cardiology|April 9, 2014
Longitudinal trends in sFas, a biomarker of apoptosis, after an acute coronary syndrome: clues to the pathogenesis underlying adverse events on follow-upHéloise Cardinal, François Madore, James M Brophy, et al.
Circulation. Cardiovascular Quality and Outcomes|December 16, 2010
Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuationJason R Guertin, Aihua Liu, Michal Abrahamowicz, et al.
International Journal of Technology Assessment in Health Care|April 25, 2019
A Framework for Aiding the Translation of Scientific Evidence into Policy: The Experience of a Hospital-Based Technology Assessment UnitNisha D Almeida, Lorraine Mines, Ioana Nicolau, et al.
AJR. American Journal of Roentgenology|February 1, 2023
Usefulness of MRI-Based Local Surveillance After Surgical Treatment of Musculoskeletal Soft-Tissue Sarcomas: A Systematic Review and Meta-AnalysisNatalia Gorelik, Samir Paruthikunnan, Aashna Uppal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 21, 2022
Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysisArthur M Albuquerque, Igor Eckert, Lucas Tramujas, et al.
Pageof 25

Showing results (191-200 of 245) with videos related to

Sort By:
Pageof 25
European Heart Journal|July 31, 2008
Discontinuation of statin therapy following an acute myocardial infarction: a population-based studyStella S Daskalopoulou, Joseph A C Delaney, Kristian B Filion, et al.
BMJ (Clinical Research Ed.)|November 7, 2013
Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodologySteven T Bird, Joseph A C Delaney, James M Brophy, et al.
Heart (British Cardiac Society)|May 21, 2014
Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndromeChristopher Labos, Rui Hao Leo Wang, Louise Pilote, et al.
Current Problems in Diagnostic Radiology|May 26, 2023
Imaging Utilization Patterns in the Follow-Up of Extremity Soft Tissue Sarcomas in the United StatesNatalia Gorelik, Elizabeth Y Rula, Casey E Pelzl, et al.
The American Journal of Cardiology|January 25, 2011
Analysis of willingness to pay for implantable cardioverter-defibrillator therapyDominika Nowakowska, Jason R Guertin, Aihua Liu, et al.
International Journal of Cardiology|April 9, 2014
Longitudinal trends in sFas, a biomarker of apoptosis, after an acute coronary syndrome: clues to the pathogenesis underlying adverse events on follow-upHéloise Cardinal, François Madore, James M Brophy, et al.
Circulation. Cardiovascular Quality and Outcomes|December 16, 2010
Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuationJason R Guertin, Aihua Liu, Michal Abrahamowicz, et al.
International Journal of Technology Assessment in Health Care|April 25, 2019
A Framework for Aiding the Translation of Scientific Evidence into Policy: The Experience of a Hospital-Based Technology Assessment UnitNisha D Almeida, Lorraine Mines, Ioana Nicolau, et al.
AJR. American Journal of Roentgenology|February 1, 2023
Usefulness of MRI-Based Local Surveillance After Surgical Treatment of Musculoskeletal Soft-Tissue Sarcomas: A Systematic Review and Meta-AnalysisNatalia Gorelik, Samir Paruthikunnan, Aashna Uppal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 21, 2022
Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysisArthur M Albuquerque, Igor Eckert, Lucas Tramujas, et al.
Pageof 25